Date: May 5, 2022 | 12PM EDT
The Blueprint Neurotherapeutics Network for Biologics (BPN-Biologics), which provides non-dilutive support for biotherapeutics discovery and development, from lead optimization through phase I clinical testing, will hold a Q&A Webinar for potential applicants on Thursday, May 5th, 2022 at 12 PM EDT. Acting Program Director Dr. Mario Skiadopoulos will provide an overview of the program and answer questions about the application process.
- PAR-21-163 Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3, Clinical Trial Optional),
- PAR-21-233 Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (U44, Clinical Trial Optional).
Next Receipt date for BPN-Biologics Funding Opportunities is August 9, 2022.
All investigators interested in learning about the BPN-Biologics are encouraged to register and participate. The webinar will be recorded and uploaded to BPN-Biologics website.
You are welcome to submit questions before the webinar to Elena Barnaeva.